🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Heart rate increase on sema — when to worry vs normal physiology

Heart rate increase on sema — when to worry vs normal physiology

Dr.RaviCardio Thu, Apr 9, 2026 at 10:07 AM 7 replies 593 viewsPage 1 of 2
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Apr 9, 2026 at 10:07 AM#1

Writing this once so I can stop repeating it across threads. It is about semaglutide, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

The condition it depends on

"tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

The practical version

For anyone assembling their own picture: Tmax is one to three days, terminal half-life about 165 to 170 hours, steady state at four to five weeks, and subcutaneous bioavailability near 89%. Those four numbers explain most of the questions people ask about timing.

What I am not sure about

So the question, as narrowly as I can put it: what the dose-response curve actually looks like above 1.7mg, because the trial means hide how few people account for the extra loss. Practical detail welcome, however dull — the duller the better.

— Dr.RaviCardio · corrections welcome and will be edited into this post with credit
30 0pete_manc_UK, anna.melb_AU, mark_tokyo and 27 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Apr 9, 2026 at 11:02 AM#2
Dr.RaviCardio said:
Steady state is the thing most people miss.

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Apr 9, 2026 at 4:02 PM
29 24traveltech_sara, AttorneyGrant, DebRD_ATL and 26 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Apr 9, 2026 at 11:57 AM#3
Dr.RaviCardio said:
Steady state is the thing most people miss.

Pushing back on Dr.RaviCardio here. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

28 23Dr.EndoIndy, tom_AK, josh_phd_bmore and 25 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Apr 9, 2026 at 12:52 PM#4

Answering the narrow version, because the broad one does not have a single answer. The mechanism that matters here is not stomach emptying, it is central. GLP-1 receptor agonism in the arcuate nucleus stimulates POMC neurons and suppresses AgRP/NPY signalling, which is why the effect is appetite and food salience rather than physical fullness. Delayed gastric emptying largely tachyphylaxes over the first months; the appetite effect does not.

27 22dan_philly, MeganSA_TX, LarryQC_SD and 24 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Apr 9, 2026 at 6:05 PM#5
LipidDoc_ATL said:
All true, with one condition: that curve is for people who reached the dose on schedule.

That holds for the injectable. The oral formulation has different absorption behaviour and the dose numbers are not interchangeable, which is worth saying out loud because people quote them as if they were.

Ask again with the specifics and you will get a better answer than this one.

26 21SleepFixSam, PurityPaulOR, MaxMetOK and 23 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register